论文部分内容阅读
目的分析经皮体外无创起博联合药物治疗严重缓慢心律失常的临床疗效。方法选取2013年1月—2015年1月佛山市第一人民医院收治的88例严重缓慢心律失常患者,采用随机数字表法分为对照组和研究组,每组44例。对照组患者给予常规药物治疗,研究组患者给予经皮体外无创起博联合药物治疗,比较两组患者临床疗效、意识恢复清醒时间、心率改善时间。结果研究组患者临床疗效优于对照组,意识恢复清醒时间和心率改善时间均短于对照组(P<0.05)。结论经皮体外无创起博联合药物治疗严重缓慢心律失常的临床疗效确切,可有效改善患者心率,促进患者意识恢复。
Objective To analyze the clinical efficacy of percutaneous noninvasive erection combined with drugs in the treatment of severe slow arrhythmia. Methods From January 2013 to January 2015, 88 patients with severe bradyarrhythmia admitted to Foshan First People’s Hospital were divided into control group and study group with 44 cases in each group. Patients in the control group were given conventional drug therapy. Patients in the study group were treated with percutaneous noninvasive erection combined with drug therapy. Clinical efficacy, consciousness recovery recovery time and heart rate improvement time were compared between the two groups. Results The clinical efficacy of the study group was better than that of the control group, and the recovery of conscious time and heart rate were shorter than that of the control group (P <0.05). Conclusion The clinical efficacy of percutaneous in vitro noninvasive erection combined with drugs in treating patients with severe slow arrhythmia can effectively improve the heart rate and promote the recovery of patients’ consciousness.